Analysis of phosphoinositide variants in gynecological cancers

Investigation of novel biomarkers by analyzing phosphoinositide variants in gynecological cancers

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1030220526

Enrollment

250

Registered

2022-12-23

Start date

2022-12-23

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ovarian cancer, endometrial cancer, cervical cancer

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Patients who received surgeries for ovarian cancer, endometrial cancer, or cervical cancer at our hospital between the date of approval by the review board and September 30, 2027, and whose tumor tissue, ascites, or blood samples are stored at the Tsukuba Human Tissue Biobank Center.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Levels of phosphoinositide variants in tumor tissue, ascites, or blood samples, results of genomic profiling by oncopanel testing, age, histopathological diagnosis, stage, overall survival, cancer-specific survival, progression-free survival, recurrence-free survival, treatment-free interval, and therapeutic efficacy, etc.	—

Contacts

Public ContactTakeo Minaguchi

University of Tsukuba Hospital

minaguchit@md.tsukuba.ac.jp+81-29-853-3073

Outcome results